Alan S. Brown, MD, FNLA

ReachMD Faculty

Public Profile

Alan S. Brown, MD, FNLA

Program Name	Last Air Date	Hosts/Guests
Meet Alan Brown, MD
Treating Erectile Dysfunction: Key Cardiovascular Considerations	12/04/2018
Pharmacometabolomics to Predict Statin Response: Ready for Prime Time?	12/14/2018
Triglyceride-Lowering Therapies: Addressing Gaps in the Guidelines	11/21/2018
PCSK9 Antibodies for Dyslipidemia: Efficacy, Safety, and Non-Lipid Effects	11/22/2018
Pathogenesis and Management of Non-Alcoholic Fatty Liver Disease	11/28/2018
Canadian Perspectives on Managing Lipid Disorders in Children	05/07/2018
Lipid-Lowering Drug Interactions in Cardiovascular Agents	11/29/2018
Selecting the Right Contraception for the Dyslipidemic Woman	03/08/2019
Lipidologists Confronting the Obesity Epidemic: Perspectives from NLA President Joyce Ross	11/02/2018
Big Data in Lipids: Refining Cardiovascular Risk Profiles Nationwide	11/15/2018
Cardiovascular Risk Reduction in the Elderly: Best Lipid Strategies	02/27/2018
What's the Deal with Saturated Fat and Cardiovascular Disease Risk?	03/01/2018
Lipidology's Advances and Growing Pains: Technologies, Drug Trials, and Guidelines	06/12/2018
The Lipidology Essentials: Making of a Specialty's Annual Summary	06/19/2018
Clinical Decisions on Cardiovascular Disease: Are Risks or Causes Your Guide?	03/29/2018
Pathways Toward Better Lipid Medication Adherence	12/07/2017
Special Populations in Patient-Centered Management of Dyslipidemia	01/02/2018
Dyslipidemia in The Elderly: How Old is "Too Old" to Treat?	01/04/2018
Guidelines for Diagnosis and Management of Dyslipidemia in Patients with HIV	01/25/2018
Updated NLA Recommendations for African American Patients	05/16/2018
Dyslipidemia in Children and Adolescents	01/22/2018
Million Hearts Initiative with Dr. Janet Wright, Executive Director	01/29/2018
Dyslipidemia During Pregnancy: The Risks for Two Patients	06/15/2018
Statin Intolerance: Keys to Patient Counseling and Guidance	01/31/2018
Roles of Non-HDL Cholesterol in Risk Assessment and Treatment	09/19/2017
Keys to the Latest NLA Recommendations for Dyslipidemia Treatments	02/01/2018
Management of the Patient With Triglycerides 200-499 mg/dl.	09/21/2017
What is the Safety of Statins in Patients with Diabetes?	09/27/2017
A Synopsis of the ACC/AHA Risk Assessment and Cholesterol Guidelines	11/20/2017
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia	12/18/2017
New Insights on Statin Therapy for Older Patients	10/05/2017
HPS-2 THRIVE Data and Results	10/19/2017
Health Information Technology's Impact on Adherence to Lipid Therapy	10/10/2017
Cardiometabolic Consequences of Sitting Time	03/17/2016
Generics and Manufacturing: What Prescribers Need to Know	10/26/2017
Genetic Testing for Familial Hypercholesterolemia	01/08/2016
Research Updates in Familial Hypercholesterolemia	02/24/2016
Research Updates on Postprandial Dyslipidemia Treatment	02/25/2016
Lipid Biomarker Updates: When to Move Beyond the Standard Profile	02/25/2016
What is HoFH: Detection and Management of the Homozygous Familial Hypercholesterolemia (HoFH) Pat...	10/13/2015
Adiposity, Obesity, and Dyslipidemia	02/18/2016
Researching Oxidized High-Density Lipoprotein in Obese Adolescents	08/29/2016
Underrecognition of Diabetes in Cardiology Practice	02/19/2016
An Avocado a Day: Does It Keep Heart Disease Away?	02/26/2016
The Impact of Inflammation on HDL Activity	09/27/2016
Changing Nutritional Needs Throughout the Lifetime	11/19/2015
Managing CVD in Women During Childbearing Years	09/03/2015
Obesity, Diabetes and the Metabolic Syndrome	03/06/2015
Broken Hearts or Broken Bones?	11/17/2015
Non-pharmacologic Approaches to the Metabolic Syndrome and Diabetes	09/25/2015
Evolving Treatments: A Review of What’s in the Pipeline	06/14/2013
Fish Oils: Are They Still Cardioprotective?	07/05/2013
Treatment Options for Polycystic Ovarian Syndrome (PCOS)	04/20/2018
Controversy Surrounding the NHLBI Pediatric Guidelines	04/03/2015
Statin Safety Considerations	08/23/2013
Emerging LDL Therapies	04/10/2015
Emerging HDL Therapies: What’s Next on the Clinical Research Horizon	03/20/2015
Understanding Why Patients Discontinue Statin Therapy	05/08/2015
Statin Therapy and Diabetes Incidence	08/28/2015
Lipids and Hormone Therapy	03/01/2013
Diet Controversies in Lipid Lowering & Cardiovascular Disease Prevention	02/22/2013
Biomarkers and Lipidology	03/08/2013
Diagnosis, Prevalence, and Screening of Familial Hypercholesterolemia	02/15/2013
Fat, Exercise and Cholesterol	03/22/2018
Managing Lipids in the Chronic Kidney Disease Patient	04/05/2018
Coronary CT Angiography	08/16/2013
Genetic Testing to Improve Risk Assessment and Guide Therapies in Patients Facing Heart Disease	07/12/2013
Management Issues in Familial Hypercholesterolemia	09/29/2016
Familial Hypercholesterolemia: Risk Stratifications in Practice	09/20/2013
From Experts to Analytics: What Does Evidence-Based Medicine Mean?	01/25/2013
CIMT Appropriate Use Guidelines	08/09/2013
Personalizing Dietary Approaches for Cardiovascular Health	08/02/2013
LDL Apheresis	10/04/2016
Imaging Guidelines for Screening CV Risk	06/15/2012
Fundamentals of Fatty Acids	06/08/2012
It's Relative: Screening and Treating Familial Hypercholesterolemia	06/22/2012
Caring for Un- and Under-Insured Patients on Lipid Therapy	09/13/2016
Current Inquiries in Lipidology: The NLA's Role in the Field	06/03/2011
Predictive Value of Lipid Biomarkers and Inflammatory Markers	05/06/2011
The Importance of Omega-3 Fatty Acids	04/29/2011
Metabolic Syndrome in African Americans: Risk Adjustments & Treatments	04/22/2011
Atherosclerosis and Cardiovascular Risk Factors in Children	04/15/2011
Cardiometabolic Risk Reduction in Native Americans	04/01/2011
The Process of Developing Clinical Guidelines	10/08/2010
Updates on the ACCORD Trial From the 2010 National Lipid Association Meeting	10/01/2010
Lipid Management and Systemic Approaches to Patient Care	09/10/2010
Heart Disease in the United States: Past, Present, and Future Trends	10/15/2010
Behavioral Strategies for Managing Weight	03/11/2011
Exercise as Medicine	03/25/2011
Using HDL in the Clinical Setting	12/24/2010
Particle Number Testing in the Prevention of Atherosclerosis	03/26/2010
Strategies to Help Reduce Diseases Associated with Lifestyle	03/25/2016
Reevaluating Heart Protective vs Destructive Dietary Fats	03/04/2011
Dietary Fats and Cardiovascular Disease	08/20/2010
Looking Beyond LDL to Reduce Cardiovascular Events	11/02/2008
The Latest Targets of Lipid Therapy	09/07/2008